These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6247049)

  • 41. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells.
    Kohl S; Loo LS; Gonik B
    J Infect Dis; 1984 Jul; 150(1):14-9. PubMed ID: 6086768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens.
    Glorioso JC; Smith JW
    J Immunol; 1977 Jan; 118(1):114-21. PubMed ID: 187696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent infection with herpes simplex virus in vitro. II. Effect of antibody on the course of herpetic persistency in Earle's L cells.
    Nii S
    Biken J; 1970 Dec; 13(4):339-52. PubMed ID: 4101736
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition of herpes simplex virus replication by succinyl concanavalin A.
    Garrity P; Szelc C; Paquette C; McEvoy M; Millette R; Adler R
    Antimicrob Agents Chemother; 1982 Mar; 21(3):450-5. PubMed ID: 6285811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of the biological activities of concanavalin A by anti-concanavalin A.
    Leon MA
    Adv Exp Med Biol; 1975; 55():261-71. PubMed ID: 1171587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of temperature on the development of immunofluorescent elements in herpes simplex virus infected BS-C-1 cells.
    Géder L; Jeney E; Gönczöl E; Lehel F
    Acta Microbiol Acad Sci Hung; 1970; 17(1):77-84. PubMed ID: 4319260
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunoglobulin binding to herpes virus-induced Fc receptors inhibits virus growth.
    Costa J; Rabson AS; Yee C; Tralka TS
    Nature; 1977 Sep; 269(5625):251-2. PubMed ID: 201851
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement.
    Tompkins WA; Seth P; Gee S; Rawls WE
    J Immunol; 1976 Feb; 116(2):489-95. PubMed ID: 175118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells of salivary polymorphonuclear leukocytes and inhibition of peripheral blood polymorphonuclear leukocyte cytotoxicity by saliva.
    Ashkenazi M; Kohl S
    J Immunol; 1990 Jun; 144(12):4781-7. PubMed ID: 1972168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.
    Kubota Y; Gaither TA; Cason J; O'Shea JJ; Lawley TJ
    J Immunol; 1987 Feb; 138(4):1137-42. PubMed ID: 3027170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defective production of antibody to herpes simplex virus in neonates: defective production of T helper lymphokine and induction of suppression.
    Kohl S; Cox PA; Loo LS
    J Infect Dis; 1987 Jun; 155(6):1179-87. PubMed ID: 3033093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting of drug loaded immunoliposomes to herpes simplex virus infected corneal cells: an effective means of inhibiting virus replication in vitro.
    Norley SG; Huang L; Rouse BT
    J Immunol; 1986 Jan; 136(2):681-5. PubMed ID: 3001182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abortive infection of LLC-MK2 cells by Herpes simplex virus.
    Nii S
    Biken J; 1972 Mar; 15(1):43-7. PubMed ID: 4341309
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface antigen produced by herpes simplex virus (HSV).
    Ito M; Barron AL
    J Immunol; 1972 Mar; 108(3):711-8. PubMed ID: 4334880
    [No Abstract]   [Full Text] [Related]  

  • 57. Concanavalin A-mediated agglutination of 3T3 cells after exposure to UV-irradiated herpes simplex virus.
    Taguchi F; Hara K; Nagaki D
    Microbiol Immunol; 1978; 22(10):597-608. PubMed ID: 216891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
    Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
    J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation and suppression of herpes simplex virus in a human T lymphoid cell line.
    Hammer SM; Richter BS; Hirsch MS
    J Immunol; 1981 Jul; 127(1):144-8. PubMed ID: 6263972
    [No Abstract]   [Full Text] [Related]  

  • 60. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells.
    Friedman HM; Cohen GH; Eisenberg RJ; Seidel CA; Cines DB
    Nature; 1984 Jun 14-20; 309(5969):633-5. PubMed ID: 6328323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.